Scarica l'app Stockscreener
39.66
8.93%
-3.89
Dopo l'orario di chiusura:
40.00
0.34
+0.86%
Nanobiotix Adr Borsa (NBTX) Ultime notizie
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's What Happened - MarketBeat
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Qatar Investment Authority (NBTX) reports 3.53M Nanobiotix ADRs under sole control - Stock Titan
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.4%What's Next? - MarketBeat
NBTXNanobiotix ADR Dividends - Finviz
NBTX Stock Price, Quote & Chart - ChartMill
5NRA Forecast — Price Target — Prediction for 2027 - TradingView
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire Inc.
NANOBIOTIX Announces Closing of Global Offering - Finansavisen
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris - Finansavisen
XP posts downbeat Q1 earnings, joins Akamai Technologies and other big stocks moving lower in Tuesday's pre-market session - MSN
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's P - Benzinga
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer - ChartMill
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighHere's What Happened - MarketBeat
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - ChartMill
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix (NASDAQ:NBTX) Trading 7.2% HigherShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Voting Rights and Shares Capital of the Company - Finansavisen
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - Finansavisen
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Ma - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market - Benzinga
0.00%
3.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):